IL17A and Alzheimer disease: Previous studies have found that the expression levels of interleukin (IL)‐1β, IL‐17, and IL‐36 are significantly elevated in the serum of patients with Alzheimer's disease (AD), ischemic stroke (IS), and traumatic brain injury (TBI), accompanied by severe neurological dysfunction.